Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. [electronic resource]
Producer: 20120802Description: e62-6 p. digitalISSN:- 1432-2277
- Adolescent
- Adult
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Child
- Female
- Glomerulosclerosis, Focal Segmental -- prevention & control
- Humans
- Kidney Transplantation -- adverse effects
- Male
- Plasmapheresis
- Recurrence
- Reoperation
- Retrospective Studies
- Risk Factors
- Rituximab
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.